Little Green Pharma has been granted a Medicinal Cannabis Cultivation and Production Permit by the Office of Drug Control (“ODC”) for its expanded cultivation and manufacturing facility. The grant of the Permit means the Expanded Facility is now fully ODC licenced and permitted.
"LGP’s Expanded Facility comprises nine flowering rooms equipped with a number of automated technologies to enhance cultivation effectiveness (including rolling benches, computer-timed LED lighting, climate control, and irrigation control), two mother plant rooms, and two vegetation rooms," the team with the company explains.
"The Expanded Facility increases the scale of LGP’s cannabis flower production sufficient to manufacture more than 110,000 bottles of medicinal cannabis oil per annum. This enhanced capacity is in addition to the Company’s well-established third-party flower and resin supply lines and will help ensure LGP can meet its growing demand requirements."
"The grant represents the achievement of a key milestone in LGP’s strategy of continued medicinal cannabis sales growth in Australia as it positions itself to become a major supplier into Germany, the UK and other key markets in Europe."
The term of the Permit is until 10 March 2021 in alignment with LGP’s Medicinal Cannabis and Manufacture licences.ODC permits are typically renewed annually or biennially on a rolling basis.
Commenting on the Permit, LGP Managing Director Fleta Solomon said: “The completion of permitting and commencement of significantly increased operations at our expanded cultivation and manufacturing facility represents the achievement of a major milestone for Little Green Pharma. We expect the increased production scale will allow us to fulfill both growing demand in Australia as well as serve as a platform to become a significant supplier into the German, UK and other key European markets.
For more information:
Little Green Pharma
PO Box 690, West Perth WA 6872
+61 8 6280 0050
[email protected]
littlegreenpharma.com